Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 2 pseudogene 15 (HMGN2P15)
- Target
- HMGN2P15
- Molecular classification
- Pseudogene, Retrogene/Processed pseudogene, Other
01
Overview
High mobility group nucleosomal binding domain 2 pseudogene 15 (HMGN2P15) is a processed pseudogene homologous to the HMGN2 gene, which encodes high mobility group proteins involved in nucleosome binding. Pseudogenes like HMGN2P15 do not produce functional proteins but may have regulatory functions at the RNA level, such as microRNA sponging, transcriptional interference, or competitive endogenous RNA activity. There is currently no evidence that HMGN2P15 itself encodes a protein or directly acts as a therapeutic target. However, downregulation of HMGN2P15 expression has been reported in certain cancer subtypes, implying a possible role as a molecular biomarker in research focused on gene expression patterns rather than as a direct drug target[2][4][7][8].
- Other names
- HMGN2P15ENSG00000214578NCBI Gene: 100288165HGNC:39020GC17M040907
02
Biological functions
Regulatory RNA functions (general for pseudogenes; may regulate parental gene expression post-transcriptionally)Possible involvement in small RNA or miRNA sponging mechanisms (known for other pseudogenes, but not specifically demonstrated for HMGN2P15)Other
03
Disease associations
Cancer (not direct causation, but downregulated in some tumor cohorts; may have a general biomarker association in expression studies)Other
04
Biomarkers
Expression downregulation noted in lung cancer and triple-negative breast cancer subgroups; function mostly unknown, possibly applicable in transcriptomic studies
Beyond the preview
Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 15 (HMGN2P15).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 15 (HMGN2P15).